Form Bio Blog

Updates and perspectives from our industry experts, scientists and product leaders.

Category
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
How Top Biotechs Use Deep Learning to Drive Development of Cell and Gene Therapy
Featured
Cell and Gene Therapy

How Top Biotechs Use Deep Learning to Drive Development of Cell and Gene Therapy

Jill Roughan, PhD

Jill Roughan, PhD

As gene therapy becomes more prevalent, so too do the challenges associated with ensuring its safety. Learn how to manufacture the purest and most potent AAV based gene therapy.

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs
Featured
Cell and Gene Therapy

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs

Nick Ketz, PhD

Nick Ketz, PhD

DeepMind researchers released a large language model (LLM) that uses fewer parameters yet achieves better performance. Read more to understand how this is relevant to your gene therapy programs.

How to leverage natural history studies to fill knowledge gaps in cell and gene therapy development
Featured
Cell and Gene Therapy

How to leverage natural history studies to fill knowledge gaps in cell and gene therapy development

Claire Aldridge, PhD

Claire Aldridge, PhD

Why are natural history studies important in cell and gene therapy development? Hear from our Chief Strategy Officer, Claire Aldridge, PhD on the importance of these studies and the need for effective data capture to make the most of them.

The Biologist’s Introduction to Computational Life Sciences
Featured
Computational Life Sciences

The Biologist’s Introduction to Computational Life Sciences

Jill Roughan, PhD

Jill Roughan, PhD

Read here for an introduction to the emerging field of computational life sciences and its broad impact and applications in solving challenging research and clinical problems.

How Computational Life Sciences Enables Metagenomics Studies
Featured
Computational Life Sciences

How Computational Life Sciences Enables Metagenomics Studies

Jill Roughan, PhD

Jill Roughan, PhD

Metagenomics studies and sophisticated computational tools advance disciplines from basic research to healthcare. Find out more in our blog.

Guest Post: What 2023 Holds for Cell and Gene Therapy
Featured
Cell and Gene Therapy

Guest Post: What 2023 Holds for Cell and Gene Therapy

ChatGPT

ChatGPT

With AI becoming not just inextricable but central for both science and software, we thought it fitting and worthwhile to utilize creative AI tools to see what 2023 might have in store for cell and gene therapy. Hence, our guest author is none other than OpenAI's ChatGPT.

Applying Data Visualization Tools to Advance Cell and Gene Therapy Research
Featured
Cell and Gene Therapy

Applying Data Visualization Tools to Advance Cell and Gene Therapy Research

Jill Roughan, PhD

Jill Roughan, PhD

The ability to interpret data is crucial to advancing cell and gene therapy research. Read on to hear how researchers are presenting data in an accessible way.

Using Deep Learning in Cell & Gene Therapy
Featured
Cell and Gene Therapy

Using Deep Learning in Cell & Gene Therapy

Jill Roughan, PhD

Jill Roughan, PhD

The power of deep learning for discovering and developing cell and gene therapies is undeniable. Learn how to implement it with these 10 actionable tips.

Sequencing and Computational Life Sciences: Making Sense of Big Genomic Data
Featured
Computational Life Sciences

Sequencing and Computational Life Sciences: Making Sense of Big Genomic Data

Jill Roughan, PhD

Jill Roughan, PhD

Sequencing technologies have seen many remarkable innovations over the last decade and shows no signs of slowing down. Read here for emerging trends.

Hear from Karlie, Our Senior Engineer, on Driving DEIB in Tech
Featured
Computational Life Sciences

Hear from Karlie, Our Senior Engineer, on Driving DEIB in Tech

Jill Roughan, PhD

Jill Roughan, PhD

Hear from Karlie, our Senior Engineer, on driving diversity, equity, inclusion and belonging (DEIB) in tech and more.

Opportunities and Challenges in Bioinformatics Software
Featured
Computational Life Sciences

Opportunities and Challenges in Bioinformatics Software

Jill Roughan, PhD

Jill Roughan, PhD

Deciding between purchasing bioinformatics software or building your own pipeline? Check out the opportunities and challenges of each.

Top 5 Take-aways from the 2022 iC3 Life Science Summit
Featured
Computational Life Sciences

Top 5 Take-aways from the 2022 iC3 Life Science Summit

Claire Aldridge, PhD

Claire Aldridge, PhD

Did you miss the 2022 iC3 Life Science Summit? No worries, read here for the top take-aways by Form’s Chief Strategy Officer.

Form Bio Resources

Board of Directors

Doe

Johnnn

Doe

,

Ph.D.

CEO
Doe

Johnn

Doe

,

Ph.D.

CEO
Doe

John

Doe

,

Ph.D.

CEO
Doe

Johnnn

Doe

,

Ph.D.

CEO

Form Bio Resources